Ryoko Tsukahara

1.7k total citations
39 papers, 1.4k citations indexed

About

Ryoko Tsukahara is a scholar working on Molecular Biology, Physiology and Biochemistry. According to data from OpenAlex, Ryoko Tsukahara has authored 39 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 9 papers in Physiology and 6 papers in Biochemistry. Recurrent topics in Ryoko Tsukahara's work include Sphingolipid Metabolism and Signaling (27 papers), Protein Kinase Regulation and GTPase Signaling (9 papers) and Peroxisome Proliferator-Activated Receptors (9 papers). Ryoko Tsukahara is often cited by papers focused on Sphingolipid Metabolism and Signaling (27 papers), Protein Kinase Regulation and GTPase Signaling (9 papers) and Peroxisome Proliferator-Activated Receptors (9 papers). Ryoko Tsukahara collaborates with scholars based in United States, Japan and China. Ryoko Tsukahara's co-authors include Gábor Tigyi, Yuko Fujiwara, Abby L. Parrill, Gábor Tigyi, Tamotsu Tsukahara, Glenn D. Prestwich, Duane D. Miller, Daniel L. Baker, James I. Fells and Jianxiong Liu and has published in prestigious journals such as Journal of Biological Chemistry, Molecular Cell and Gastroenterology.

In The Last Decade

Ryoko Tsukahara

38 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryoko Tsukahara United States 22 1.2k 361 185 142 115 39 1.4k
Makiko Umezu‐Goto United States 9 1.3k 1.1× 483 1.3× 200 1.1× 174 1.2× 156 1.4× 10 1.5k
Ruijuan Xu United States 25 1.4k 1.1× 443 1.2× 361 2.0× 136 1.0× 70 0.6× 50 1.6k
Patrick Roddy United States 21 1.6k 1.3× 416 1.2× 349 1.9× 105 0.7× 73 0.6× 25 1.8k
Mandi M. Murph United States 23 1.6k 1.3× 506 1.4× 103 0.6× 111 0.8× 97 0.8× 44 1.9k
Samer El Bawab United States 19 1.3k 1.0× 263 0.7× 213 1.2× 83 0.6× 61 0.5× 41 1.6k
Elad L. Laviad Israel 15 1.4k 1.1× 302 0.8× 391 2.1× 225 1.6× 28 0.2× 16 1.5k
Scott L. Schissel United States 12 1.2k 1.0× 350 1.0× 400 2.2× 86 0.6× 79 0.7× 16 1.7k
K. Kishta Reddy United States 17 1.1k 0.9× 494 1.4× 272 1.5× 323 2.3× 42 0.4× 23 1.8k
Shuhei Ishikura Japan 21 922 0.8× 619 1.7× 232 1.3× 91 0.6× 28 0.2× 57 1.4k
Laura Strittmatter United States 6 2.2k 1.8× 209 0.6× 299 1.6× 61 0.4× 73 0.6× 6 2.5k

Countries citing papers authored by Ryoko Tsukahara

Since Specialization
Citations

This map shows the geographic impact of Ryoko Tsukahara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryoko Tsukahara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryoko Tsukahara more than expected).

Fields of papers citing papers by Ryoko Tsukahara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryoko Tsukahara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryoko Tsukahara. The network helps show where Ryoko Tsukahara may publish in the future.

Co-authorship network of co-authors of Ryoko Tsukahara

This figure shows the co-authorship network connecting the top 25 collaborators of Ryoko Tsukahara. A scholar is included among the top collaborators of Ryoko Tsukahara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryoko Tsukahara. Ryoko Tsukahara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tanaka, Keigo, Jun Nagai, Ryoko Tsukahara, et al.. (2021). Secreted PLA2-III is a possible therapeutic target to treat neuropathic pain. Biochemical and Biophysical Research Communications. 568. 167–173. 8 indexed citations
2.
Tsukahara, Tamotsu, Nigel Ribeiro, Ryoko Tsukahara, et al.. (2021). Adenine nucleotide translocase 2, a putative target protein for 2-carba cyclic phosphatidic acid in microglial cells. Cellular Signalling. 82. 109951–109951. 6 indexed citations
3.
Shimizu, Yoshibumi, Shinji Yamamoto, Ryoko Tsukahara, et al.. (2020). Evaluation of the pharmacokinetics of 2-carba-cyclic phosphatidic acid by liquid chromatography-triple quadrupole mass spectrometry. Prostaglandins & Other Lipid Mediators. 150. 106450–106450. 3 indexed citations
4.
Tsukahara, Ryoko, Hisao Haniu, Yoshikazu Yonei, & Tamotsu Tsukahara. (2018). The AGP-PPARγ axis promotes oxidative stress and diabetic endothelial cell dysfunction. Molecular and Cellular Endocrinology. 473. 100–113. 5 indexed citations
5.
Tsukahara, Ryoko, Shinji Yamamoto, Keisuke Yoshikawa, et al.. (2018). LPA5 signaling is involved in multiple sclerosis-mediated neuropathic pain in the cuprizone mouse model. Journal of Pharmacological Sciences. 136(2). 93–96. 22 indexed citations
6.
7.
Tsukahara, Tamotsu, Ryoko Tsukahara, Hisao Haniu, Yoshikazu Yonei, & Kimiko Murakami‐Murofushi. (2015). Cyclic phosphatidic acid inhibits the secretion of vascular endothelial growth factor from diabetic human coronary artery endothelial cells through peroxisome proliferator-activated receptor gamma. Molecular and Cellular Endocrinology. 412. 320–329. 13 indexed citations
8.
Lee, Sue-Chin, Yuko Fujiwara, Jianxiong Liu, et al.. (2014). Autotaxin and LPA1 and LPA5 Receptors Exert Disparate Functions in Tumor Cells versus the Host Tissue Microenvironment in Melanoma Invasion and Metastasis. Molecular Cancer Research. 13(1). 174–185. 72 indexed citations
9.
Tsukahara, Tamotsu, Ryoko Tsukahara, Yuko Fujiwara, et al.. (2010). Phospholipase D2-Dependent Inhibition of the Nuclear Hormone Receptor PPARγ by Cyclic Phosphatidic Acid. Molecular Cell. 39(3). 421–432. 101 indexed citations
10.
Fells, James I., Ryoko Tsukahara, Jianxiong Liu, Gábor Tigyi, & Abby L. Parrill. (2010). 2D binary QSAR modeling of LPA3 receptor antagonism. Journal of Molecular Graphics and Modelling. 28(8). 828–833. 6 indexed citations
11.
Zhang, Honglu, Xiaoyu Xu, Joanna Gajewiak, et al.. (2009). Dual Activity Lysophosphatidic Acid Receptor Pan-Antagonist/Autotaxin Inhibitor Reduces Breast Cancer Cell Migration In vitro and Causes Tumor Regression In vivo. Cancer Research. 69(13). 5441–5449. 132 indexed citations
12.
Cheng, Yunhui, Natalia Makarova, Ryoko Tsukahara, et al.. (2009). Lysophosphatidic acid-induced arterial wall remodeling: Requirement of PPARγ but not LPA1 or LPA2 GPCR. Cellular Signalling. 21(12). 1874–1884. 33 indexed citations
13.
Khandoga, Anna L., Anna L. Khandoga, Yasuhiro Fujiwara, et al.. (2008). Lysophosphatidic acid-induced platelet shape change revealed through LPA1–5receptor-selective probes and albumin. Platelets. 19(6). 415–427. 38 indexed citations
14.
Jiang, Guowei, Yong Xu, Yuko Fujiwara, et al.. (2007). α‐Substituted Phosphonate Analogues of Lysophosphatidic Acid (LPA) Selectively Inhibit Production and Action of LPA. ChemMedChem. 2(5). 679–690. 88 indexed citations
15.
Valentine, William J., Yuko Fujiwara, Ryoko Tsukahara, & Gábor Tigyi. (2007). Lysophospholipid signaling: Beyond the EDGs. Biochimica et Biophysica Acta (BBA) - General Subjects. 1780(3). 597–605. 21 indexed citations
16.
Liliom, Károly, et al.. (2006). Farnesyl phosphates are endogenous ligands of lysophosphatidic acid receptors: Inhibition of LPA GPCR and activation of PPARs. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1761(12). 1506–1514. 24 indexed citations
17.
Qian, Lian, Yong Xu, Guowei Jiang, et al.. (2006). Phosphorothioate Analogues of Alkyl Lysophosphatidic Acid as LPA3 Receptor‐Selective Agonists. ChemMedChem. 1(3). 376–383. 27 indexed citations
18.
Gududuru, Veeresa, Kui Zeng, Ryoko Tsukahara, et al.. (2005). Identification of Darmstoff analogs as selective agonists and antagonists of lysophosphatidic acid receptors. Bioorganic & Medicinal Chemistry Letters. 16(2). 451–456. 34 indexed citations
19.
Durgam, Gangadhar G., Ryoko Tsukahara, Natalia Makarova, et al.. (2005). Synthesis and pharmacological evaluation of second-generation phosphatidic acid derivatives as lysophosphatidic acid receptor ligands. Bioorganic & Medicinal Chemistry Letters. 16(3). 633–640. 42 indexed citations
20.
Tsukahara, Tamotsu, Ryoko Tsukahara, Satoshi Yasuda, et al.. (2005). Different Residues Mediate Recognition of 1-O-Oleyllysophosphatidic Acid and Rosiglitazone in the Ligand Binding Domain of Peroxisome Proliferator-activated Receptor γ. Journal of Biological Chemistry. 281(6). 3398–3407. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Makiko Umezu‐Goto Breakdown of academic impact, for papers by Ruijuan Xu Breakdown of academic impact, for papers by Patrick Roddy Breakdown of academic impact, for papers by Mandi M. Murph Breakdown of academic impact, for papers by Samer El Bawab Breakdown of academic impact, for papers by Elad L. Laviad Breakdown of academic impact, for papers by Scott L. Schissel Breakdown of academic impact, for papers by K. Kishta Reddy Breakdown of academic impact, for papers by Shuhei Ishikura Breakdown of academic impact, for papers by Laura Strittmatter
Rankless by CCL
2026